GenePath Diagnostics Inc.

GenePath Dx, founded in 2008 in Ann Arbor, Michigan, designs and manufactures high-performance PCR and NGS reagents for infectious disease, oncology, and genetic testing. Operating in 14 global markets, we help CLIA labs create cost-effective LDTs, improving margins up to 30% with over a decade of R&D expertise.